Heisz Leslie Stone - Feb 16, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
Director
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Feb 16, 2023
Transactions value $
-$397,912
Form type
4
Date filed
2/16/2023, 05:21 PM
Previous filing
May 5, 2022
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $345K +9.67K +35.19% $35.68 37.2K Feb 16, 2023 Direct
transaction EW Common Stock Sale -$743K -9.67K -26.03% $76.82 27.5K Feb 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Director Stock Option (Right to Acquire) Options Exercise $0 -9.67K -100% $0.00* 0 Feb 16, 2023 Common Stock 9.67K $35.68 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $76.71 to $76.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.